Study received £2.8m of Department of Health and Social Care funding to find out if testing can identify which immunosuppressed people remain at greatest risk.
Ulcerative colitis assessment could be improved after new research shows that an AI model could predict flare-ups and complications after reading biopsies.
Bacterial infections kill over 7 million people each year and the development of new and better vaccines will reduce this devastating burden of disease.
University of Birmingham researchers have received a £1.8M grant by the NIHR EME Programme investigating BCG vaccine efficacy in reducing COPD exacerbations.
The IMPROVE clinical trial is testing whether vaccine timing can help clinically vulnerable people build antibodies
Patients had 44% higher risk of death in hospital compared to those with healthy immune system function
New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
Two University of Birmingham researchers have been awarded prestigious Medical Research Council (MRC) clinical fellowships this year.
Broad T-cell response is currently protective but recognition of seven out of ten T-cell targets mutated in SARS-CoV-2 variants is impaired
Blood tests will identify children likely to develop type 1 diabetes, allowing earlier, safer diagnosis
The International Eosinophil Society announces University of Birmingham researcher as a winner of the Gerald J. Gleich Award 2022.
The largest analysis of data on antibody therapies for protecting clinically extremely vulnerable people from Covid-19 shows that they are effective.